Bone Therapeutics

General presentation

Specializing in the treatment of musculoskeletal diseases through cell therapy, Bone Therapeutics develops innovative products for cellular reconstruction and regeneration of bone and cartilage, based on proprietary technology. The company's competitiveness is based on: the pioneering work of its scientific founders in stem cell transplantation, an excellent knowledge of bone diseases and their pathophysiology, unique technical and clinical know-how and a non-invasive surgical approach.

Two clinical programs are currently underway in the treatment of orphan bone diseases and in the treatment of "non-union” fractures. Bone Therapeutics is expanding its product portfolio by developing new cell populations and new products including cells embedded in matrices.
The Company is working closely with the Rheumatology and Orthopaedics departments at the Hôpital Erasme (ULB, Brussels, Belgium) and the CHU Sart-Tilman (ULg, Liege, Belgium) as well as on joint projects with the Department of Orthopaedics at the Hôpital St Luc (UCL, Brussels, Belgium).

Domains of specialization

• Biotechnologies